Company: NMP
Filing Date: 2025-04-09
Form Type: DRS/A
Source: 0001213900-25-030132
Chunk: 107

Company: NMP Acquisition Corp.
Filing Date: 2025-04-09
Form: DRS/A
Chunk 107
---
 members in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. The non -managingsponsor members have expressed to us an interest in purchasing up to an aggregate of approximately [__] units in this offering at the offering price (assuming the exercise in full of the underwriters’ over -allotmentoption), or up to [__]% of this offering. None of the non -managingsponsor members has expressed to us an interest in purchasing more than 9.9% of the units to be sold in this offering. Because these expressions of interest are not binding agreements or commitments to purchase, the non -managingsponsor members may determine to purchase fewer units in this offering, or none at all. In addition, the underwriters have full discretion to allocate the units to investors and may determine to sell fewer units to the non -managingsponsor members, or none at all, and the purchase of the non -managingsponsor membership interests is not contingent upon the participation in this offering or vice -versa. Depending on how many units are purchased by the non -managingsponsor members, the post -offeringtrading volume, volatility and liquidity of our securities may be reduced relative to what they would have been had the units been more widely offered and sold to other public investors. We do not expect any purchase of units by the non -managingsponsor members or a limited number of public investors in this offering to negatively impact our ability to meet Nasdaq listing eligibility requirements as we expect to comply with all of the Nasdaq listing requirements prior to the effective date of the registration statement of which this prospectus forms a part. We may amend the terms of the rights in a way that may be adverse to holders with the approval by the holders of a majority of the then outstanding rights. Our rights will be issued in registered form under a rights agreement between Continental Stock Transfer & Trust Company, as rights agent, and us. The rights agreement provides that the terms of the rights may be amended without the consent of any holder to cure any ambiguity or correct any defective provision. The rights agreement requires the approval by the holders of a majority of the then outstanding rights in order to make any change that adversely affects the interests of the registered holders. 70 Our rights and founder shares may have an adverse effect on the market price of our Class A ordinary shares and make it more difficult to effectuate our initial business combination. We will be issuing rights to receive 2,